An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.
<h4>Background</h4>There has been widespread interest in the potential of combination cardiovascular medications containing aspirin and agents to lower blood pressure and cholesterol ('polypills') to reduce cardiovascular disease. However, no reliable placebo-controlled data ar...
Guardado en:
Autores principales: | PILL Collaborative Group, Anthony Rodgers, Anushka Patel, Otavio Berwanger, Michiel Bots, Richard Grimm, Diederick E Grobbee, Rod Jackson, Bruce Neal, Jim Neaton, Neil Poulter, Natasha Rafter, P Krishnam Raju, Srinath Reddy, Simon Thom, Stephen Vander Hoorn, Ruth Webster |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16dd80222e3b4ed69eabb956c7b80aed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.
por: C Raina Elley, et al.
Publicado: (2012) -
The Concept of the Polypill in the Prevention of Cardiovascular Disease
por: Brandon Wiley, et al.
Publicado: (2014) -
Polypill eligibility and equivalent intake in a Swiss population-based study
por: Julien Castioni, et al.
Publicado: (2021) -
Raising in Berber
por: Fatima Sadiqi
Publicado: (1986) -
Modification of Apremilast from Pills to Aerosol a Future Concept
por: Paul Zarogoulidis, et al.
Publicado: (2021)